KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Other Non Operating Income (2016 - 2023)

TherapeuticsMD filings provide 12 years of Other Non Operating Income readings, the most recent being $359000.0 for Q3 2023.

  • On a quarterly basis, Other Non Operating Income rose 420.54% to $359000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $880000.0, a 110.33% increase, with the full-year FY2022 number at -$117000.0, down 143.01% from a year prior.
  • Other Non Operating Income hit $359000.0 in Q3 2023 for TherapeuticsMD, up from $103000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $12.6 million in Q4 2019 to a low of -$10.1 million in Q2 2019.
  • Median Other Non Operating Income over the past 5 years was $103000.0 (2023), compared with a mean of -$154104.5.
  • Biggest five-year swings in Other Non Operating Income: surged 1425.79% in 2019 and later crashed 6985.25% in 2022.
  • TherapeuticsMD's Other Non Operating Income stood at $12.6 million in 2019, then tumbled by 98.95% to $132000.0 in 2020, then tumbled by 93.94% to $8000.0 in 2021, then soared by 37.5% to $11000.0 in 2022, then skyrocketed by 3163.64% to $359000.0 in 2023.
  • The last three reported values for Other Non Operating Income were $359000.0 (Q3 2023), $103000.0 (Q2 2023), and $407000.0 (Q1 2023) per Business Quant data.